Table: Takara Bio - 9-MTH group results
Feb 13 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2024 Dec 31, 2023 Mar 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 29.28 29.73 45.50
(-1.5 pct) (-50.6 pct) (+4.6 pct)
Operating loss 1.47 336 mln 3.00
(-98.3 pct) (-0.1 pct)
Recurring loss 1.26 586 mln 3.00
(-97.0 pct) (-11.9 pct)
Net loss 1.38 154 mln 1.00
(-98.9 pct) (-32.5 pct)
EPS loss 11.45 yen 1.28 yen 8.30 yen
Ann Div 17.00 yen 17.00 yen
-Q2 div NIL NIL
-Q4 div 17.00 yen 17.00 yen
NOTE - Takara Bio Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T